Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Material Type
3.3. Snippet by Design
3.4. Snippet by Application
3.5. Snippet by Distribution Channels
3.6. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising FDA Approvals of Prefilled Syringes
4.1.1.2. Increasing Clinical Trials for Prefilled Syringes
4.1.2. Restraints
4.1.2.1. Significant Challenges Possessed with the Prefilled Syringes
4.1.3. Opportunity
4.1.3.1. Emerging Markets of Prefilled Syringes
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. Russia-Ukraine War Analysis
8. By Product Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.1.2. Market Attractiveness Index, By Product Type
8.2. Needle Free PFS*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Needled PFS
9. By Material Type
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
9.1.2. Market Attractiveness Index, By Material Type
9.2. Glass Prefilled Syringes*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Plastic Prefilled Syringes
10. By Design
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
10.1.2. Market Attractiveness Index, By Design
10.2. Single Chamber PFS
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Dual Chamber PFS
11. By Application
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.1.2. Market Attractiveness Index, By Application
11.2. Diabetes
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Rheumatoid Arthritis
11.4. Ophthalmology
11.5. Anaphylaxis
11.6. Others
12. By Distribution Channels
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channels
12.1.2. Market Attractiveness Index, By Distribution Channels
12.2. Hospitals
12.2.1. Introduction
12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3. Clinics
12.4. Ambulatory Centers
13. By Region
13.1. Introduction
13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
13.1.2. Market Attractiveness Index, By Region
13.2. North America
13.2.1. Introduction
13.2.2. Key Region-Specific Dynamics
13.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
13.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
13.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
13.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
13.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channels
13.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
13.2.8.1. U.S.
13.2.8.2. Canada
13.2.8.3. Mexico
13.3. Europe
13.3.1. Introduction
13.3.2. Key Region-Specific Dynamics
13.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
13.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
13.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
13.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channels
13.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
13.3.7.1. Germany
13.3.7.2. U.K.
13.3.7.3. France
13.3.7.4. Italy
13.3.7.5. Spain
13.3.7.6. Rest of Europe
13.4. South America
13.4.1. Introduction
13.4.2. Key Region-Specific Dynamics
13.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
13.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
13.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
13.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channels
13.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
13.4.7.1. Brazil
13.4.7.2. Argentina
13.4.7.3. Rest of South America
13.5. Asia Pacific
13.5.1. Introduction
13.5.2. Key Region-Specific Dynamics
13.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
13.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
13.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
13.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
13.5.6.1. China
13.5.6.2. India
13.5.6.3. Japan
13.5.6.4. Australia
13.5.6.5. Rest of Asia Pacific
13.6. Middle East and Africa
13.6.1. Introduction
13.6.2. Key Region-Specific Dynamics
13.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
13.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
13.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
13.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
13.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channels
14. Competitive Landscape
14.1. Competitive Scenario
14.2. Product Benchmarking
14.3. Company Share Analysis
14.4. Key Developments and Strategies
15. Company Profiles
15.1. Gerresheimer AG*
15.1.1. Company Overview
15.1.2. Product Portfolio and Description
15.1.3. Financial Overview
15.1.4. Key Developments
15.2. Sanofi
15.3. Terumo Corporation
15.4. B. Braun
15.5. Baxter International
15.6. West Pharmaceutical Services, Inc.
15.7. Becton, Dickinson and Company
15.8. SCHOTT AG
15.9. Catalent Inc.
15.10. Cardinal Health Inc.
LIST NOT EXHAUSTIVE
16. Appendix
16.1. About Us and Services
16.2. Contact Us